These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 23084849
1. The economic value of a quadrivalent versus trivalent influenza vaccine. Lee BY, Bartsch SM, Willig AM. Vaccine; 2012 Dec 14; 30(52):7443-6. PubMed ID: 23084849 [Abstract] [Full Text] [Related]
3. Public health and economic impact of seasonal influenza vaccination with quadrivalent influenza vaccines compared to trivalent influenza vaccines in Europe. Uhart M, Bricout H, Clay E, Largeron N. Hum Vaccin Immunother; 2016 Sep 14; 12(9):2259-68. PubMed ID: 27166916 [Abstract] [Full Text] [Related]
6. Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom. Thommes EW, Ismaila A, Chit A, Meier G, Bauch CT. BMC Infect Dis; 2015 Oct 27; 15():465. PubMed ID: 26503131 [Abstract] [Full Text] [Related]
7. From trivalent to quadrivalent influenza vaccines: Public health and economic burden for different immunization strategies in Spain. Crépey P, Redondo E, Díez-Domingo J, Ortiz de Lejarazu R, Martinón-Torres F, Gil de Miguel Á, López-Belmonte JL, Alvarez FP, Bricout H, Solozabal M. PLoS One; 2020 Oct 27; 15(5):e0233526. PubMed ID: 32437476 [Abstract] [Full Text] [Related]
9. Cost-Effectiveness of Quadrivalent versus Trivalent Influenza Vaccine in the United States. de Boer PT, Crépey P, Pitman RJ, Macabeo B, Chit A, Postma MJ. Value Health; 2016 Dec 27; 19(8):964-975. PubMed ID: 27987647 [Abstract] [Full Text] [Related]
10. Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong. You JH, Ming WK, Chan PK. BMC Infect Dis; 2014 Nov 25; 14():618. PubMed ID: 25420713 [Abstract] [Full Text] [Related]
15. Cost Effectiveness of Quadrivalent Influenza Vaccines Compared with Trivalent Influenza Vaccines in Young Children and Older Adults in Korea. Kim YK, Song JY, Jang H, Kim TH, Koo H, Varghese L, Han E. Pharmacoeconomics; 2018 Dec 25; 36(12):1475-1490. PubMed ID: 30251078 [Abstract] [Full Text] [Related]
16. Cost-Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in the Dutch National Influenza Prevention Program. Zeevat F, Crépey P, Dolk FCK, Postma AJ, Breeveld-Dwarkasing VNA, Postma MJ. Value Health; 2021 Jan 25; 24(1):3-10. PubMed ID: 33431150 [Abstract] [Full Text] [Related]
17. Cost-Utility of Quadrivalent Versus Trivalent Influenza Vaccine in Germany, Using an Individual-Based Dynamic Transmission Model. Dolk C, Eichner M, Welte R, Anastassopoulou A, Van Bellinghen LA, Poulsen Nautrup B, Van Vlaenderen I, Schmidt-Ott R, Schwehm M, Postma M. Pharmacoeconomics; 2016 Dec 25; 34(12):1299-1308. PubMed ID: 27647004 [Abstract] [Full Text] [Related]